title: Coronary endothelial dysfunction and impaired microcirculation response to atrial natriuretic peptide in hyperinsulinemia.
abstract: Endothelial dysfunction occurs in hyperinsulinemia (HI). Coronary microcirculation responses to vasoactive agents are examined in 57 patients with angiographically normal coronary arteries. Patients were divided into 2 groups, 37 with normoinsulinemia (NI) and 20 with HI based on results of a 75-g oral glucose tolerance test. Epicardial artery vasoactivity in response to acetylcholine chloride is measured to assess endothelial function. Coronary microcirculation function is evaluated by intracoronary administration of 50 microg of adenosine triphosphate, 1 mg of isosorbide dinitrate, and 0.05 mg/kg of atrial natriuretic peptide. Epicardial artery vasoconstriction in response to 100 microg of acetylcholine is mildly reduced in HI (P = .04). Coronary flow reserve in response to adenosine triphosphate in NI is similar to that in HI. In NI, the resting mean (SD) peak velocity in response to isosorbide dinitrate (40.7 [10.9] cm/s) vs atrial natriuretic peptide (39.6 [10.9] cm/s) is similar. In contrast, the resting mean (SD) peak velocity in response to atrial natriuretic peptide (31.3 [9.3] cm/s) vs isosorbide dinitrate (43.5 [10.0] cm/s) in HI is statistically significantly blunted (P < .001). Atrial natriuretic peptide may have a pathologic effect on coronary microcirculation even in mild endothelial dysfunction among patients with HI.
authors.affiliation: Department of Cardiology, Yokohama Minami Kyosai Hospital, 1-21-1 Mutsuurahigashi, Kanazawa-ku, Yokohama City, Kanagawa 236-0037, Japan. ashikaga-ind@umin.ac.jp
authors.forename: Takashi
authors.initials: T
authors.lastname: Ashikaga
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Nishizaki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Fujii
authors.forename: Kensuke
authors.initials: K
authors.lastname: Ihara
authors.forename: Saori
authors.initials: S
authors.lastname: Niki
authors.forename: Tadashi
authors.initials: T
authors.lastname: Murai
authors.forename: Shingo
authors.initials: S
authors.lastname: Maeda
authors.forename: Noriyoshi
authors.initials: N
authors.lastname: Yamawake
authors.forename: Yukio
authors.initials: Y
authors.lastname: Kishi
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Isobe
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D003331:Coronary Vessels / Q000187:drug effects / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006946:Hyperinsulinism / Q000503:physiopathology*; D007548:Isosorbide Dinitrate / Q000494:pharmacology; D008297:Male; D008833:Microcirculation / Q000187:drug effects / Q000503:physiopathology*; D008875:Middle Aged; D014661:Vasoconstriction / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D014665:Vasodilator Agents; D009320:Atrial Natriuretic Factor; D000255:Adenosine Triphosphate; D007548:Isosorbide Dinitrate; D000109:Acetylcholine